A brief report on the mutational landscape in non-small cell lung cancer of South Asian patients: Comparison at a US and an Indian Institution

Background: Various molecular underpinnings of lung cancer have been noted in Asian populations, especially with targetable oncogenic drivers such as EGFR mutations and ALK rearrangements, although they have been lesser described in South Asian/Indian patients. Methods: Tumour molecular testing resu...

Full description

Bibliographic Details
Main Authors: Mohana Roy, Amanjit Bal, Nalini Gupta, Kuruswamy T Prasad, Heather A Wakelee, Navneet Singh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Lung India
Subjects:
Online Access:http://www.lungindia.com/article.asp?issn=0970-2113;year=2022;volume=39;issue=4;spage=315;epage=318;aulast=Roy
_version_ 1798037394461556736
author Mohana Roy
Amanjit Bal
Nalini Gupta
Kuruswamy T Prasad
Heather A Wakelee
Navneet Singh
author_facet Mohana Roy
Amanjit Bal
Nalini Gupta
Kuruswamy T Prasad
Heather A Wakelee
Navneet Singh
author_sort Mohana Roy
collection DOAJ
description Background: Various molecular underpinnings of lung cancer have been noted in Asian populations, especially with targetable oncogenic drivers such as EGFR mutations and ALK rearrangements, although they have been lesser described in South Asian/Indian patients. Methods: Tumour molecular testing results from non-small cell lung cancer (NSCLC) patients with a name of South Asian origin and diagnosed from 2005 to 2019 at the Stanford Cancer Center in the United States were retrospectively reviewed and compared to the results of molecular testing from PGIMER in Chandigarh, India, from the patients diagnosed from 2011 to 2019. Results: We identified 72 patients of South Asian (largely Indian) origin, of whom 64 patients (51% female) had mutational testing at Stanford. Of the tested patients, 33% of cases harboured either an EGFR exon 19 deletion or exon 21 L858R mutation, and 12.5% had ALK rearrangements. At PGIMER, a larger sample of 1,264 patients was identified (33% female), with 22.5% of patients having two main EGFR activating mutations, and 9.5% harbouring an ALK rearrangement. Conclusions: South Asian, largely Indian, patients with NSCLC appear to have a higher chance of harbouring EGFR mutations and ALK translocation as compared to Caucasians. The percentage of South Asian patients with these molecular abnormalities was largely similar in two different geographical locations. These findings corroborate prior single-institution findings and emphasise the importance of molecular testing.
first_indexed 2024-04-11T21:25:59Z
format Article
id doaj.art-9dae7f7b4c724acd9f64a861a9fe2771
institution Directory Open Access Journal
issn 0970-2113
0974-598X
language English
last_indexed 2024-04-11T21:25:59Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Lung India
spelling doaj.art-9dae7f7b4c724acd9f64a861a9fe27712022-12-22T04:02:24ZengWolters Kluwer Medknow PublicationsLung India0970-21130974-598X2022-01-0139431531810.4103/lungindia.lungindia_428_21A brief report on the mutational landscape in non-small cell lung cancer of South Asian patients: Comparison at a US and an Indian InstitutionMohana RoyAmanjit BalNalini GuptaKuruswamy T PrasadHeather A WakeleeNavneet SinghBackground: Various molecular underpinnings of lung cancer have been noted in Asian populations, especially with targetable oncogenic drivers such as EGFR mutations and ALK rearrangements, although they have been lesser described in South Asian/Indian patients. Methods: Tumour molecular testing results from non-small cell lung cancer (NSCLC) patients with a name of South Asian origin and diagnosed from 2005 to 2019 at the Stanford Cancer Center in the United States were retrospectively reviewed and compared to the results of molecular testing from PGIMER in Chandigarh, India, from the patients diagnosed from 2011 to 2019. Results: We identified 72 patients of South Asian (largely Indian) origin, of whom 64 patients (51% female) had mutational testing at Stanford. Of the tested patients, 33% of cases harboured either an EGFR exon 19 deletion or exon 21 L858R mutation, and 12.5% had ALK rearrangements. At PGIMER, a larger sample of 1,264 patients was identified (33% female), with 22.5% of patients having two main EGFR activating mutations, and 9.5% harbouring an ALK rearrangement. Conclusions: South Asian, largely Indian, patients with NSCLC appear to have a higher chance of harbouring EGFR mutations and ALK translocation as compared to Caucasians. The percentage of South Asian patients with these molecular abnormalities was largely similar in two different geographical locations. These findings corroborate prior single-institution findings and emphasise the importance of molecular testing.http://www.lungindia.com/article.asp?issn=0970-2113;year=2022;volume=39;issue=4;spage=315;epage=318;aulast=Royalkegfrmutational analysisnsclc
spellingShingle Mohana Roy
Amanjit Bal
Nalini Gupta
Kuruswamy T Prasad
Heather A Wakelee
Navneet Singh
A brief report on the mutational landscape in non-small cell lung cancer of South Asian patients: Comparison at a US and an Indian Institution
Lung India
alk
egfr
mutational analysis
nsclc
title A brief report on the mutational landscape in non-small cell lung cancer of South Asian patients: Comparison at a US and an Indian Institution
title_full A brief report on the mutational landscape in non-small cell lung cancer of South Asian patients: Comparison at a US and an Indian Institution
title_fullStr A brief report on the mutational landscape in non-small cell lung cancer of South Asian patients: Comparison at a US and an Indian Institution
title_full_unstemmed A brief report on the mutational landscape in non-small cell lung cancer of South Asian patients: Comparison at a US and an Indian Institution
title_short A brief report on the mutational landscape in non-small cell lung cancer of South Asian patients: Comparison at a US and an Indian Institution
title_sort brief report on the mutational landscape in non small cell lung cancer of south asian patients comparison at a us and an indian institution
topic alk
egfr
mutational analysis
nsclc
url http://www.lungindia.com/article.asp?issn=0970-2113;year=2022;volume=39;issue=4;spage=315;epage=318;aulast=Roy
work_keys_str_mv AT mohanaroy abriefreportonthemutationallandscapeinnonsmallcelllungcancerofsouthasianpatientscomparisonatausandanindianinstitution
AT amanjitbal abriefreportonthemutationallandscapeinnonsmallcelllungcancerofsouthasianpatientscomparisonatausandanindianinstitution
AT nalinigupta abriefreportonthemutationallandscapeinnonsmallcelllungcancerofsouthasianpatientscomparisonatausandanindianinstitution
AT kuruswamytprasad abriefreportonthemutationallandscapeinnonsmallcelllungcancerofsouthasianpatientscomparisonatausandanindianinstitution
AT heatherawakelee abriefreportonthemutationallandscapeinnonsmallcelllungcancerofsouthasianpatientscomparisonatausandanindianinstitution
AT navneetsingh abriefreportonthemutationallandscapeinnonsmallcelllungcancerofsouthasianpatientscomparisonatausandanindianinstitution
AT mohanaroy briefreportonthemutationallandscapeinnonsmallcelllungcancerofsouthasianpatientscomparisonatausandanindianinstitution
AT amanjitbal briefreportonthemutationallandscapeinnonsmallcelllungcancerofsouthasianpatientscomparisonatausandanindianinstitution
AT nalinigupta briefreportonthemutationallandscapeinnonsmallcelllungcancerofsouthasianpatientscomparisonatausandanindianinstitution
AT kuruswamytprasad briefreportonthemutationallandscapeinnonsmallcelllungcancerofsouthasianpatientscomparisonatausandanindianinstitution
AT heatherawakelee briefreportonthemutationallandscapeinnonsmallcelllungcancerofsouthasianpatientscomparisonatausandanindianinstitution
AT navneetsingh briefreportonthemutationallandscapeinnonsmallcelllungcancerofsouthasianpatientscomparisonatausandanindianinstitution